Openbookopenbook
Equity
Becton Dickinson & Co.(0R19)
USD --+0.00%
Reward45Moderate
Risk44Moderate
📊75%Data
2.8% dividend yield
0R19
+0.0 · +0.00%
USD · LSE
Becton Dickinson & Co. |
Balanced
Market Cap:—
ℹ️
Reward Rating
45
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
44
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0R19 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Becton Dickinson & Co.?

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

0R19 · Verdict

Moderate reward · moderate risk

0R19 stands out on volatility and cash flow, but watch the balance sheet signal.

Based on 88% data coverage

0R19 · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Cash flow74/100

    12% free-cash-flow margin

Watchouts 3

  • Balance sheet35/100

    Interest covered 4.1×

  • Growth43/100

    Rev +5.0% CAGR · earnings -1.9%

  • Valuation43/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Becton Dickinson & Co.?

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. The company is listed on the LSE in UK, and a P/E ratio of 0.2x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (45)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio0.2306
Dividend Yield2.80%
52 Week High198.7014
52 Week Low125.4741
Last AnnualSeptember
IPO DateN/A
IncorporatedUK
Shares Outstanding268M
No. of Employees70,000
IndustryN/A
ExchangeLSE
Beta0.352
CurrencyUSD
Websitewww.bd.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.